199 related articles for article (PubMed ID: 8568137)
1. Salbutamol-induced increased airway responsiveness to allergen and reduced protection versus methacholine: dose response.
Bhagat R; Swystun VA; Cockcroft DW
J Allergy Clin Immunol; 1996 Jan; 97(1 Pt 1):47-52. PubMed ID: 8568137
[TBL] [Abstract][Full Text] [Related]
2. Interaction of inhaled beta 2 agonist and inhaled corticosteroid on airway responsiveness to allergen and methacholine.
Cockcroft DW; Swystun VA; Bhagat R
Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1485-9. PubMed ID: 7582281
[TBL] [Abstract][Full Text] [Related]
3. Regular inhaled salbutamol and airway responsiveness to allergen.
Cockcroft DW; McParland CP; Britto SA; Swystun VA; Rutherford BC
Lancet; 1993 Oct; 342(8875):833-7. PubMed ID: 8104272
[TBL] [Abstract][Full Text] [Related]
4. Regular inhaled salbutamol : effect on airway responsiveness to methacholine and adenosine 5'-monophosphate and tolerance to bronchoprotection.
Jokic R; Swystun VA; Davis BE; Cockcroft DW
Chest; 2001 Feb; 119(2):370-5. PubMed ID: 11171711
[TBL] [Abstract][Full Text] [Related]
5. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
Kalra S; Swystun VA; Bhagat R; Cockcroft DW
Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376
[TBL] [Abstract][Full Text] [Related]
6. Salbutamol tolerance to bronchoprotection: course of onset.
Stewart SL; Martin AL; Davis BE; Cockcroft DW
Ann Allergy Asthma Immunol; 2012 Dec; 109(6):454-7. PubMed ID: 23176887
[TBL] [Abstract][Full Text] [Related]
7. Rapid onset of tolerance to the bronchoprotective effect of salmeterol.
Bhagat R; Kalra S; Swystun VA; Cockcroft DW
Chest; 1995 Nov; 108(5):1235-9. PubMed ID: 7587422
[TBL] [Abstract][Full Text] [Related]
8. Dose-response protective effect of salbutamol on methacholine airway responsiveness using pressurized metered dose inhalers and Turbuhalers.
Wong AG; O'Byrne PM; Lindbladh C; Inman MD; Stâhl E; Hargreave FE
Can Respir J; 1998; 5(2):119-23. PubMed ID: 9707454
[TBL] [Abstract][Full Text] [Related]
9. Effects of long-acting and short-acting beta-agonists on methacholine dose-response curves in asthmatics.
Wong AG; O'Shaughnessy AD; Walker CM; Sears MR
Eur Respir J; 1997 Feb; 10(2):330-6. PubMed ID: 9042628
[TBL] [Abstract][Full Text] [Related]
10. The utility of methacholine airway responsiveness measurements in evaluating anti-asthma drugs.
Inman MD; Hamilton AL; Kerstjens HA; Watson RM; O'Byrne PM
J Allergy Clin Immunol; 1998 Mar; 101(3):342-8. PubMed ID: 9525450
[TBL] [Abstract][Full Text] [Related]
11. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
van der Woude HJ; Winter TH; Aalbers R
Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
[TBL] [Abstract][Full Text] [Related]
12. Tolerance to the bronchoprotective effect of beta2-agonists: comparison of the enantiomers of salbutamol with racemic salbutamol and placebo.
Cockcroft DW; Davis BE; Swystun VA; Marciniuk DD
J Allergy Clin Immunol; 1999 Jun; 103(6):1049-53. PubMed ID: 10359885
[TBL] [Abstract][Full Text] [Related]
13. Dose equivalence and bronchoprotective effects of salmeterol and salbutamol in asthma.
Higham MA; Sharara AM; Wilson P; Jenkins RJ; Glendenning GA; Ind PW
Thorax; 1997 Nov; 52(11):975-80. PubMed ID: 9487346
[TBL] [Abstract][Full Text] [Related]
14. Regular use of inhaled albuterol and the allergen-induced late asthmatic response.
Cockcroft DW; O'Byrne PM; Swystun VA; Bhagat R
J Allergy Clin Immunol; 1995 Jul; 96(1):44-9. PubMed ID: 7622762
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.
Cheung D; Timmers MC; Zwinderman AH; Bel EH; Dijkman JH; Sterk PJ
N Engl J Med; 1992 Oct; 327(17):1198-203. PubMed ID: 1357550
[TBL] [Abstract][Full Text] [Related]
16. Protection against methacholine bronchoconstriction to assess relative potency of inhaled beta2-agonist.
Parameswaran KN; Inman MD; Ekholm BP; Morris MM; Summers E; O'Byrne PM; Hargreave FE
Am J Respir Crit Care Med; 1999 Jul; 160(1):354-7. PubMed ID: 10390425
[TBL] [Abstract][Full Text] [Related]
17. Effect of single doses of S-salbutamol, R-salbutamol, racemic salbutamol, and placebo on the airway response to methacholine.
Cockcroft DW; Swystun VA
Thorax; 1997 Oct; 52(10):845-8. PubMed ID: 9404369
[TBL] [Abstract][Full Text] [Related]
18. Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial.
Haney S; Hancox RJ
Respir Res; 2005 Sep; 6(1):107. PubMed ID: 16168062
[TBL] [Abstract][Full Text] [Related]
19. An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist.
Yates DH; Kharitonov SA; Barnes PJ
Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1603-7. PubMed ID: 8970342
[TBL] [Abstract][Full Text] [Related]
20. The effect of glycopyrronium and indacaterol, as monotherapy and in combination, on the methacholine dose-response curve of mild asthmatics: a randomized three-way crossover study.
Blais CM; Davis BE; Cockcroft DW
Respir Res; 2017 Aug; 18(1):146. PubMed ID: 28768531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
